Eli Lilly’s Cheaper Weight Loss Med Comes With a Catch
Weight and Healthcare · Ragen Chastain
Audio is streamed directly from the publisher (api.substack.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Eil Lilly has recently announced that they are going to sell their weight loss drug, Zepbound, directly to consumers who can’t get insurance coverage and don’t qualify for other cost-lowering programs. They are going to do that through their private pharmacy Lilly Direct.
The subject of whether drug companies should have their own pharmacies is a topic for another day.
I’ve previously done deep dives into the research and claims made about these weight loss medications. I do not think they are going to live up to the hype and I think people aren’t getting appropriate informed consent around these drugs.
Still, I believe in bodily autonomy and I think that people who choose to take these medications deserve a safe experience.
What I want to talk about today is the catch of Lilly’s direct drug discount. That catch is the delivery system.
Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe